loadpatents
name:-0.031991958618164
name:-0.026742935180664
name:-0.013865947723389
Gu; Wenxin Patent Filings

Gu; Wenxin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gu; Wenxin.The latest application filed is for "substituted quinoxaline dna-pk inhibitors".

Company Profile
14.23.30
  • Gu; Wenxin - Concord MA
  • Gu; Wenxin - Evanston IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted Quinoxaline Dna-pk Inhibitors
App 20210236505 - Maxwell; John Patrick ;   et al.
2021-08-05
Pteridinone compounds and uses thereof
Grant 11,059,826 - Lauffer , et al. July 13, 2
2021-07-13
Substituted quinoxaline DNA-PK inhibitors
Grant 10,973,830 - Maxwell , et al. April 13, 2
2021-04-13
Dna-pk Inhibitors
App 20210069203 - Maxwell; John Patrick ;   et al.
2021-03-11
Inhibitors Of Influenza Viruses Replication
App 20210040092 - Charifson; Paul S. ;   et al.
2021-02-11
Inhibitors of influenza viruses replication
Grant 10,875,855 - Charifson , et al. December 29, 2
2020-12-29
Inhibitors of influenza viruses replication
Grant 10,874,673 - Charifson , et al. December 29, 2
2020-12-29
DNA-PK inhibitors
Grant 10,786,512 - Maxwell , et al. September 29, 2
2020-09-29
Triazoles for the treatment of demyelinating dieases
Grant 10,766,869 - Davies , et al. Sep
2020-09-08
Pteridinone Compounds And Uses Thereof
App 20190322673 - Lauffer; David J. ;   et al.
2019-10-24
Dna-pk Inhibitors
App 20190290654 - Maxwell; John Patrick ;   et al.
2019-09-26
Dna-pk Inhibitors
App 20190255062 - Maxwell; John Patrick ;   et al.
2019-08-22
Triazoles For The Treatment Of Demyelinating Diseases
App 20190185436 - Davies; Robert J. ;   et al.
2019-06-20
Inhibitors Of Influenza Viruses Replication
App 20190151314 - Charifson; Paul S. ;   et al.
2019-05-23
DNA-PK inhibitors
Grant 10,258,627 - Maxwell , et al.
2019-04-16
Triazoles for the treatment of Demyelinating Diseases
Grant 10,118,904 - Davies , et al. November 6, 2
2018-11-06
Dna-pk Inhibitors
App 20180311254 - Maxwell; John Patrick ;   et al.
2018-11-01
1,3-substituted Pyrazole Compounds Useful For Reduction Of Very Long Chain Fatty Acid Levels
App 20180251431 - Charifson; Paul S. ;   et al.
2018-09-06
Inhibitors of influenza viruses replication
Grant 10,039,762 - Charifson , et al. August 7, 2
2018-08-07
Dna-pk Inhibitors
App 20180161336 - Maxwell; John Patrick ;   et al.
2018-06-14
Inhibitors Of Influenza Viruses Replication
App 20180155342 - Charifson; Paul S. ;   et al.
2018-06-07
Substituted benzooxadiazole DNA-PK inhibitors
Grant 9,987,284 - Maxwell , et al. June 5, 2
2018-06-05
Inhibitors Of Influenza Viruses Replication
App 20180078553 - Charifson; Paul S. ;   et al.
2018-03-22
Inhibitors of influenza viruses replication
Grant 9,908,878 - Charifson , et al. March 6, 2
2018-03-06
Inhibitors of influenza viruses replication
Grant 9,808,459 - Charifson , et al. November 7, 2
2017-11-07
Inhibitors Of Influenza Viruses Replication
App 20170100400 - Charifson; Paul S. ;   et al.
2017-04-13
Inhibitors of influenza viruses replication
Grant 9,518,056 - Charifson , et al. December 13, 2
2016-12-13
Inhibitors Of Influenza Viruses Replication
App 20160355512 - Charifson; Paul S. ;   et al.
2016-12-08
Triazoles For The Treatment Of Demyelinating Diseases
App 20160355488 - Davies; Robert J. ;   et al.
2016-12-08
Dna-pk Inhibitors
App 20160354381 - Maxwell; John Patrick ;   et al.
2016-12-08
Dna-pk Inhibitors
App 20160340341 - Maxwell; John Patrick ;   et al.
2016-11-24
Inhibitors of influenza viruses replication
Grant 9,394,302 - Charifson , et al. July 19, 2
2016-07-19
DNA-PK inhibitors
Grant 9,359,380 - Maxwell , et al. June 7, 2
2016-06-07
Inhibitors Of Influenza Viruses Replication
App 20160152614 - Charifson; Paul S. ;   et al.
2016-06-02
Inhibitors of influenza viruses replication
Grant 9,345,708 - Charifson , et al. May 24, 2
2016-05-24
Substituted quinoxaline DNA-PK inhibitors
Grant 9,340,557 - Maxwell , et al. May 17, 2
2016-05-17
Inhibitors Of Influenza Viruses Replication
App 20150191468 - Charifson; Paul S. ;   et al.
2015-07-09
Inhibitors of influenza viruses replication
Grant 9,051,319 - Charifson , et al. June 9, 2
2015-06-09
Inhibitors Of Influenza Viruses Replication
App 20140296201 - Charifson; Paul S. ;   et al.
2014-10-02
Inhibitors of influenza viruses replication
Grant 8,829,007 - Charifson , et al. September 9, 2
2014-09-09
Inhibitors Of Influenza Viruses Replication
App 20140142119 - Charifson; Paul S. ;   et al.
2014-05-22
Inhibitors Of Influenza Viruses Replication
App 20140094473 - Charifson; Paul S. ;   et al.
2014-04-03
Inhibitors Of Influenza Viruses Replication
App 20130345218 - Charifson; Paul S. ;   et al.
2013-12-26
Cyclic peptide antitumor agents
Grant 8,492,345 - Silverman , et al. July 23, 2
2013-07-23
Inhibitors Of Influenza Viruses Replication
App 20120171245 - Charifson; Paul S. ;   et al.
2012-07-05
Cyclic Peptide Antitumor Agents
App 20120122799 - Silverman; Richard B. ;   et al.
2012-05-17
Cyclic peptide antitumor agents
Grant 8,058,244 - Silverman , et al. November 15, 2
2011-11-15
Cyclic Peptide Antitumor Agents
App 20100204088 - Silverman; Richard B. ;   et al.
2010-08-12
Cyclic peptide antitumor agents
Grant 7,709,443 - Silverman , et al. May 4, 2
2010-05-04
Cyclic peptide antitumor agents
App 20050159346 - Silverman, Richard B. ;   et al.
2005-07-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed